MARINUS PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q3 2024.
  • Marinus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.83M, a 20.6% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $18.9M, a 19.9% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15.6M, a 4.52% increase from 2022.
  • Marinus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14.9M, a 9.58% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.6M, a 82.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $18.9M $4.83M +$824K +20.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $18M $4.92M +$1.03M +26.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $17M $5.19M +$1.45M +38.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $15.6M $3.93M -$175K -4.27% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $15.7M $4.01M +$111K +2.85% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $15.6M $3.89M +$74K +1.94% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $15.6M $3.74M +$663K +21.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $14.9M $4.1M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $3.9M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.82M +$907K +31.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $3.08M -$1.9M -38.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q2 2021 $2.91M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $4.98M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q2 2016 $738K +$350K +90.2% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $739K +$356K +93% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-02
Q3 2015 $597K +$381K +176% Jul 1, 2015 Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $388K +$364K +1517% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $383K +$360K +1565% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q3 2014 $216K Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-29
Q2 2014 $24K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $23K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.